These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 21839367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C, Fremeaux-Bacchi V.
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [Abstract] [Full Text] [Related]

  • 3. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [Abstract] [Full Text] [Related]

  • 4. Membranoprolferative glomerulonephritis - mechanisms and treatment.
    Appel GB.
    Contrib Nephrol; 2013 Mar; 181():163-74. PubMed ID: 23689578
    [Abstract] [Full Text] [Related]

  • 5. Histopathology of MPGN and C3 glomerulopathies.
    Cook HT, Pickering MC.
    Nat Rev Nephrol; 2015 Jan; 11(1):14-22. PubMed ID: 25447133
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M, Donadelli R, Remuzzi G.
    Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
    Iatropoulos P, Noris M, Mele C, Piras R, Valoti E, Bresin E, Curreri M, Mondo E, Zito A, Gamba S, Bettoni S, Murer L, Fremeaux-Bacchi V, Vivarelli M, Emma F, Daina E, Remuzzi G.
    Mol Immunol; 2016 Mar; 71():131-142. PubMed ID: 26895476
    [Abstract] [Full Text] [Related]

  • 11. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
    Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G, Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy, Nastasi.
    J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
    [Abstract] [Full Text] [Related]

  • 12. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion.
    Sethi S, Nester CM, Smith RJ.
    Kidney Int; 2012 Mar; 81(5):434-41. PubMed ID: 22157657
    [Abstract] [Full Text] [Related]

  • 13. Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
    Kersnik Levart T, Ferluga D, Vizjak A, Mraz J, Kojc N.
    Diagn Pathol; 2016 Oct 07; 11(1):94. PubMed ID: 27717365
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.
    Bomback AS, Appel GB.
    Nat Rev Nephrol; 2012 Nov 07; 8(11):634-42. PubMed ID: 23026947
    [Abstract] [Full Text] [Related]

  • 16. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.
    Mol Immunol; 2009 Sep 07; 46(14):2801-7. PubMed ID: 19640589
    [Abstract] [Full Text] [Related]

  • 17. Membranoproliferative glomerulonephritis with isolated C3 deposits: case report and literature review.
    Darouich S, Goucha R, Jaafoura MH, Zekri S, Kheder A, Ben Maiz H.
    Ultrastruct Pathol; 2011 Feb 07; 35(1):42-6. PubMed ID: 21265634
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).
    Jansen JH, Høgåsen K, Mollnes TE.
    Am J Pathol; 1993 Nov 07; 143(5):1356-65. PubMed ID: 8238252
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.